MedPath

VA Office of Research and Development

Ownership
Private
Employees
-
Market Cap
-
Website

Cognitive Rehabilitation and Brain Activity of Attention Control in TBI

Not Applicable
Withdrawn
Conditions
Brain Injuries, Traumatic
Interventions
Behavioral: Direct-attention training using web-based BrainHQ
Behavioral: Goal Management Training (GMT)
First Posted Date
2015-10-28
Last Posted Date
2022-02-15
Lead Sponsor
VA Office of Research and Development
Registration Number
NCT02589509
Locations
🇺🇸

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States

Comparative Effectiveness of Two Treatments for Veterans With PTSD

Not Applicable
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Behavioral: Interpersonal Therapy for PTSD
Behavioral: Prolonged Exposure
First Posted Date
2015-10-26
Last Posted Date
2021-07-07
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
115
Registration Number
NCT02586064
Locations
🇺🇸

Southeast Louisiana Veterans Health Care System, New Orleans, LA, New Orleans, Louisiana, United States

🇺🇸

Providence VA Medical Center, Providence, RI, Providence, Rhode Island, United States

Optimizing Dementia Care

Not Applicable
Completed
Conditions
Veterans
Dementia
Dementia, Vascular
Caregivers
Alzheimer's Disease
Interventions
Behavioral: Care Consultation (CC)
Behavioral: Counseling (C)
First Posted Date
2015-10-23
Last Posted Date
2022-01-11
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
86
Registration Number
NCT02585232
Locations
🇺🇸

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States

Reducing Colorectal Cancer Death Through Mailed Outreach Screening

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Other: Screening invitation-reminder
Other: Mailed-FIT
First Posted Date
2015-10-23
Last Posted Date
2018-12-24
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
782
Registration Number
NCT02584998
Locations
🇺🇸

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States

CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat

Phase 4
Completed
Conditions
Chronic Kidney Diseases
Gout
Interventions
Drug: Placebo, vehicle control (allopurinol-shaped)
Drug: Placebo, vehicle control (febuxostat-shaped)
First Posted Date
2015-10-19
Last Posted Date
2024-03-29
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
950
Registration Number
NCT02579096
Locations
🇺🇸

VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda, California, United States

🇺🇸

Asheville VA Medical Center, Asheville, NC, Asheville, North Carolina, United States

🇺🇸

Sanford Bismarck Medical Center ? RAIN 2, Bismarck, North Dakota, United States

and more 20 locations

Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence

Phase 1
Completed
Conditions
Tobacco
Posttraumatic Stress Disorder
Interventions
Behavioral: Acceptance and Commitment Therapy for PTSD and Tobacco Use
Behavioral: Freedom From Smoking
First Posted Date
2015-10-15
Last Posted Date
2020-04-10
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
36
Registration Number
NCT02576899
Locations
🇺🇸

Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, Bedford, Massachusetts, United States

Brief Behavioral Insomnia Treatment Study

Not Applicable
Completed
Conditions
Insomnia Disorder
Interventions
Behavioral: Progressive Muscle Relaxation
Behavioral: Brief Behavioral Treatment for Insomnia
First Posted Date
2015-10-08
Last Posted Date
2020-02-07
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
93
Registration Number
NCT02571452
Locations
🇺🇸

San Francisco VA Medical Center, San Francisco, CA, San Francisco, California, United States

Microbiome and Metagenome in Percutaneous Osseointegrated Prostheses (MMPOP)

Completed
Conditions
Transfemoral Amputation
First Posted Date
2015-09-30
Last Posted Date
2020-02-19
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
10
Registration Number
NCT02564432
Locations
🇺🇸

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States

Ketamine for Treatment Resistant Late-Life Depression

Phase 3
Completed
Conditions
Treatment Resistant Depressive Disorder
Interventions
First Posted Date
2015-09-22
Last Posted Date
2022-01-11
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
33
Registration Number
NCT02556606
Locations
🇺🇸

Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States

Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)

Not Applicable
Completed
Conditions
Speech Disorders
Apraxia of Speech
Aphasia, Acquired
Interventions
Device: EPG Tx
Behavioral: SPT
First Posted Date
2015-09-18
Last Posted Date
2021-11-04
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
6
Registration Number
NCT02554513
Locations
🇺🇸

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath